Sulfamethizole: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
| verifiedrevid = 470473060 | | verifiedrevid = 470473060 | ||
| IUPAC_name = 4-amino-''N''-(5-methyl-1,3,4-thiadiazol-2-yl)- benzenesulfonamide | | IUPAC_name = 4-amino-''N''-(5-methyl-1,3,4-thiadiazol-2-yl)- benzenesulfonamide | ||
| image = Sulfamethizole. | | image = Sulfamethizole.png | ||
| width = 250 | | width = 250 | ||
| Line 58: | Line 58: | ||
| StdInChIKey = VACCAVUAMIDAGB-UHFFFAOYSA-N | | StdInChIKey = VACCAVUAMIDAGB-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Sulfamethizole''' is a [[sulfonamide (medicine)|sulfonamide]] [[antibiotic]]. | '''Sulfamethizole''' is a [[sulfonamide (medicine)|sulfonamide]] [[antibiotic]]. | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
* {{cite journal | author = Ratanajamit C, Skriver M, Nørgaard M, Jepsen P, Schønheyder H, Sørensen H | title = Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study. | journal = J Antimicrob Chemother | volume = 52 | issue = 5 | pages = 837–41 | year = 2003 | pmid = 14519675 | doi = 10.1093/jac/dkg438}} | * {{cite journal | author = Ratanajamit C, Skriver M, Nørgaard M, Jepsen P, Schønheyder H, Sørensen H | title = Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study. | journal = J Antimicrob Chemother | volume = 52 | issue = 5 | pages = 837–41 | year = 2003 | pmid = 14519675 | doi = 10.1093/jac/dkg438}} | ||
* {{cite journal | author = Kerrn M, Frimodt-Møller N, Espersen F | title = Effects of Sulfamethizole and Amdinocillin against Escherichia coli Strains (with Various Susceptibilities) in an Ascending Urinary Tract Infection Mouse Model | journal = Antimicrob Agents Chemother | volume = 47 | issue = 3 | pages = 1002–9 | year = 2003 | pmid = 12604534 | doi = 10.1128/AAC.47.3.1002-1009.2003 | pmc = 149286}} | * {{cite journal | author = Kerrn M, Frimodt-Møller N, Espersen F | title = Effects of Sulfamethizole and Amdinocillin against Escherichia coli Strains (with Various Susceptibilities) in an Ascending Urinary Tract Infection Mouse Model | journal = Antimicrob Agents Chemother | volume = 47 | issue = 3 | pages = 1002–9 | year = 2003 | pmid = 12604534 | doi = 10.1128/AAC.47.3.1002-1009.2003 | pmc = 149286}} | ||
| Line 69: | Line 77: | ||
[[Category:Sulfonamide antibiotics]] | [[Category:Sulfonamide antibiotics]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 14:45, 13 April 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a682231 |
| ATC code | |
| Pharmacokinetic data | |
| Protein binding | 98–99% |
| Elimination half-life | 3–8 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C9H10N4O2S2 |
| Molar mass | 270.333 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
|
WikiDoc Resources for Sulfamethizole |
|
Articles |
|---|
|
Most recent articles on Sulfamethizole Most cited articles on Sulfamethizole |
|
Media |
|
Powerpoint slides on Sulfamethizole |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Sulfamethizole at Clinical Trials.gov Trial results on Sulfamethizole Clinical Trials on Sulfamethizole at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Sulfamethizole NICE Guidance on Sulfamethizole
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Sulfamethizole Discussion groups on Sulfamethizole Patient Handouts on Sulfamethizole Directions to Hospitals Treating Sulfamethizole Risk calculators and risk factors for Sulfamethizole
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Sulfamethizole |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Sulfamethizole is a sulfonamide antibiotic.
References
- Ratanajamit C, Skriver M, Nørgaard M, Jepsen P, Schønheyder H, Sørensen H (2003). "Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study". J Antimicrob Chemother. 52 (5): 837–41. doi:10.1093/jac/dkg438. PMID 14519675.
- Kerrn M, Frimodt-Møller N, Espersen F (2003). "Effects of Sulfamethizole and Amdinocillin against Escherichia coli Strains (with Various Susceptibilities) in an Ascending Urinary Tract Infection Mouse Model". Antimicrob Agents Chemother. 47 (3): 1002–9. doi:10.1128/AAC.47.3.1002-1009.2003. PMC 149286. PMID 12604534.
- Watanabe H, Hastings J (1990). "Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine". Biochim Biophys Acta. 1017 (3): 229–34. doi:10.1016/0005-2728(90)90189-B. PMID 2372557.